The Community Resource in Targeted Therapies
Driving Knowledge. Empowering Change. Optimizing Outcomes.
ONCAlert | Upfront Therapy for mRCC

Predicting Risk of Recurrence for Women With DCIS

Eileen Rakovitch, MD
Published Online: 5:06 PM, Fri December 12, 2014
Eileen Rakovitch, MD, associate professor, radiation oncologist, Sunnybrook Health Sciences Centre, Toronto, Ontario, discusses predicting risk of recurrence in women with DCIS.

Clinical Pearls

  • Oncotype DX DCIS Score was validated as a predictor of risk of recurrence among women treated with breast-conserving surgery alone for DCIS.
  • Women with a low-risk DCIS Score had a significantly lower risk of recurrence.
  • Every 50 point increase in DCIS Score was associated with a two-fold increase in risk of recurrence.

<<< Go back to the SABCS conference page

Copyright © TargetedOnc 2018 Intellisphere, LLC. All Rights Reserved.